Overview

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if daily teriparatide reduces back pain more effectively than weekly risedronate in women with osteoporosis who have chronic back pain due to a spinal bone fracture.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid
Teriparatide